In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology have developed a technology that transforms colon cancer cells into normal-like cells without destroying them. The approach is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe side effects and risks of recurrence. The KAIST team targeted the root causes of cancer development, and validated their findings through molecular experiments, cellular studies, and animal trials. While the study focused on colon cancer, the principles could be extended to other cancer types. As the technology develops, it may redefine how we combat cancer.
More: